CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) FOR ADVANCED GASTRIC CANCER

被引：0
|
作者：
Maeda, O. [1 ]
Ando, T. [2 ]
Ishiguro, K. [1 ]
Watanabe, O. [2 ]
Miyahara, R. [2 ]
Funasaka, K. [3 ]
Ando, Y. [4 ]
Goto, H. [2 ,3 ]
机构：
[1] Nagoya Univ, Dept Adv Res Gastroenterol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[2] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[3] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan
[4] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [31] Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
    Luigi Di Lauro
    Patrizia Vici
    Franca Belli
    Silverio Tomao
    Silvia Ileana Fattoruso
    Maria Grazia Arena
    Laura Pizzuti
    Diana Giannarelli
    Giancarlo Paoletti
    Maddalena Barba
    Domenico Sergi
    Marcello Maugeri-Saccà
    Gastric Cancer, 2014, 17 : 718 - 724
  • [32] A phase II trial of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.
    Lu, YS
    Kuo, SH
    Su, WP
    Yang, CH
    Hsu, C
    Yang, TL
    Huang, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 93S - 93S
  • [33] Capecitabine/cisplatin effective in advanced gastric cancer patients
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 814 - +
  • [34] Perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    Thuss-Patience, P. C.
    Hofheinz, R.
    Arnold, D.
    Florschuetz, A.
    Daum, S.
    Kretzschmar, A.
    Mantovani-Loeffler, L.
    Bichev, D.
    Gahn, B.
    Schumacher, G.
    Kneba, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] European experience of docetaxel and cisplatin in advanced gastric cancer
    Arnaud D. Roth
    Gastric Cancer, 2002, 5 (Suppl 1) : 27 - 29
  • [36] Docetaxel, cisplatin, and capecitabine (DCX) as perioperative chemotherapy in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    Thuss-Patience, P. C.
    Kneba, M.
    Hofheinz, R.
    Arnold, D.
    Florschuetz, A.
    Daum, S.
    Kretzschmar, A.
    Mantovani-Loeffler, L.
    Bichev, D.
    Schumacher, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] A phase II study of neoadjuvant chemotherapy with docetaxel, capecitabine and cisplatin (DXP) in patients with advanced unresectable or intra-abdominal metastatic gastric cancer
    Sym, S.
    Chang, H.
    Ryu, M.
    Lee, J.
    Kim, T.
    Yook, J.
    Oh, S.
    Kim, B.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Phase II study with docetaxel (D), cisplatin (C) and continuous capecitabine (X) schedule (DCX) in advanced gastric cancer (AGC): ML21085. Final results.
    Pericay, Caries
    Losa, Ferran
    Alfaro, Jordi
    Cirera, Luis
    Pisa, Aleydis
    Salud, Antonieta
    Falco, Esther
    Casado, Esther
    Nogue, Miguel
    Dotor, Emma
    Serra, Olbia
    Fernandez, Julen
    Saigi, Eugeni
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel - Cisplatin
    Polyzos, Aristides
    Tsavaris, Nikolas
    Kosmas, Christos
    Polyzos, Kostas
    Giannopoulos, Athanasios
    Felekouras, Evangelos
    Nikiteas, Nikolas
    Kouraklis, Gregory
    Griniatsos, John
    Safioleas, Michael
    Stamatakos, Michael
    Pikoulis, Emmanuel
    Papachristodoulou, Antonios
    Gogas, Helen
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3749 - 3753
  • [40] DOCETAXEL, CISPLATIN, 5-FLUOROURACIL CHEMOTHERAPY IN YOUNG KOREAN PATIENTS WITH ADVANCED GASTRIC CANCER
    Shim, H.
    Cho, M.
    Park, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 88 - 88
12345